The link between p53 activation (tumor suppression) and the absence of CDK19 described here suggested that osteosarcomas bearing deletions in chromosome 6q16-6q23 may selectively possess p53 gain-of-function mutations; however, no correlation could be found among the few documented chromosomal deletion samples. This evidence concerns the gene CDK19 and osteosarcoma.